Immunic AG | WebDisclosure

COMMUNIQUÉ DE PRESSE

publié le 30/04/2025 à 13:30, il y a 1 année 5 mois

Immunic Announces Vidofludimus Calcium Reduced Risk of Disability Worsening by 30% in Primary Progressive Multiple Sclerosis Patients from Phase 2 CALLIPER Trial
Immunic announces positive results from Phase 2 CALLIPER trial showing 30% reduced risk of disability worsening in Primary Progressive Multiple Sclerosis patients with vidofludimus calcium. Webcast scheduled for April 30

Multiple Sclerosis Immunic Vidofludimus Calcium Phase 2 CALLIPER Trial
BRÈVE

publiée le 10/04/2025 à 19:05, il y a 1 année 6 mois

Immunic Closes $5.1 Million Direct Offering Led by Aberdeen Investments

Biotechnology Chronic Diseases Direct Offering Aberdeen Investments Immunic Funding
BRÈVE

publiée le 10/04/2025 à 19:05, il y a 1 année 6 mois

Immunic clôture une offre directe de 5,1 millions de dollars menée par Aberdeen Investments

Biotechnologie Maladies Chroniques Offre Directe Investissements Aberdeen Financement Immunitaire
COMMUNIQUÉ DE PRESSE

publié le 10/04/2025 à 19:00, il y a 1 année 6 mois

Immunic, Inc. Announces Closing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. closes $5.1 million direct offering led by Aberdeen Investments to fund clinical trials and operations for autoimmune diseases. Issued via PRNewswire

Clinical Trials Immunic Inc. Autoimmune Diseases Direct Offering Aberdeen Investments
BRÈVE

publiée le 09/04/2025 à 14:15, il y a 1 année 6 mois

Immunic, Inc. Announces $5.1 Million Direct Offering Guided by Aberdeen Investments

Biotechnology Nasdaq Investment Immunic, Inc. Direct Offering
BRÈVE

publiée le 09/04/2025 à 14:15, il y a 1 année 6 mois

Immunic, Inc. annonce une offre directe de 5,1 millions de dollars, pilotée par Aberdeen Investments

Investissement Biotechnologie Nasdaq Immunic, Inc. Offre Directe
COMMUNIQUÉ DE PRESSE

publié le 09/04/2025 à 14:10, il y a 1 année 6 mois

Immunic, Inc. Announces Pricing of $5.1 Million Registered Direct Offering, Led by Aberdeen Investments
Immunic, Inc. announces pricing of $5.1 million registered direct offering led by Aberdeen Investments for clinical pipeline of therapies. Funds to be used for clinical trials and operations

Registered Direct Offering Immunic Inc. Clinical Pipeline Thérapies Aberdeen Investments
BRÈVE

publiée le 01/04/2025 à 12:35, il y a 1 année 6 mois

Immunic, Inc. Announces Participation in Key April Conferences

Biotechnology Conférences Immunic Inc. Vidofludimus Calcium Neuroprotection
BRÈVE

publiée le 01/04/2025 à 12:35, il y a 1 année 6 mois

Immunic, Inc. annonce sa participation aux principales conférences d'avril

Biotechnologie Conférences Immunic Inc. Neuroprotection Vidofludimus Calcique
COMMUNIQUÉ DE PRESSE

publié le 01/04/2025 à 12:30, il y a 1 année 6 mois

Immunic, Inc. to Participate in Scientific and Industry Conferences in April
Immunic, Inc. to participate in scientific and industry conferences in April, including American Academy of Neurology 2025 Annual Meeting and German Biotech Days 2025

Immunic Inc. Industry Conferences Scientific Conferences American Academy Of Neurology German Biotech Days

Publié le 09/10/2026 à 19:27, il y a 1 jour 2 heures

Disclosure of transactions in own shares from October 1 to October 9, 2026
Publié le 09/10/2026 à 19:27, il y a 1 jour 2 heures

Déclaration hebdomadaire d'opérations effectuées du 1er au 9 octobre 2026
Publié le 09/10/2026 à 18:01, il y a 1 jour 3 heures

Titre de mon communiqué
Publié le 09/10/2026 à 18:01, il y a 1 jour 3 heures

Title of my press release
Publié le 09/10/2026 à 17:45, il y a 1 jour 4 heures

Déclaration des droits de vote à fin septembre 2026

Voir tout LES ECHOS COMFI WIRE

Publié le 10/10/2026 à 04:45, il y a 17 heures

Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Publié le 10/10/2026 à 02:03, il y a 19 heures 42 minutes

BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Publié le 10/10/2026 à 02:00, il y a 19 heures 45 minutes

Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Publié le 09/10/2026 à 23:00, il y a 22 heures 45 minutes

Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Publié le 09/10/2026 à 22:15, il y a 23 heures 30 minutes

Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call

Voir tout ACCESSWIRE

Publié le 10/10/2026 à 16:35, il y a 5 heures 10 minutes

New Opportunities for Global Cooperation: Kexing Biopharm Shines at CPHI Milan 2026
Publié le 10/10/2026 à 16:30, il y a 5 heures 15 minutes

ZPMC-Built Infrastructure Supports China's First Offshore Wind Project to Deploy 18 MW Turbines at Scale
Publié le 10/10/2026 à 10:05, il y a 11 heures 40 minutes

ONLYOFFICE 10.0 brings AI tools, modular apps, and stronger security to its open-source office suite
Publié le 09/10/2026 à 21:24, il y a 1 jour

Branicks Group AG: Extraordinary General Meeting does not approve all items on the agenda
Publié le 09/10/2026 à 21:17, il y a 1 jour

EQS-Adhoc: Branicks Group AG: Agenda topic four at extraordinary general meeting rejected

Voir tout EQS

News